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Exposure to high doses of ionizing radiation is associated with damage to the heart and coronary arteries. However,
only recently have studies with high-quality individual dosimetry data allowed this risk to be estimated while adjusting
for concomitant chemotherapy. An association between lower dose exposures and late-occurring circulatory disease
has only recently been suspected in the Japanese atomic bomb survivors and in various occupationally exposed
cohorts and is still controversial. Excess relative risks per unit dose in moderate- and low-dose epidemiological
studies are variable, possibly resulting from confounding and effect-modification by well known (but unobserved)
risk factors. Here, we summarize the evidence for a causal association between moderate- and low-level radiation
exposure (whether at high or low dose rates) and circulatory disease.
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Circulatory disease is the leading cause of death in the
developed world [1]. There are many types of circulatory
disease [2]. Consistently identified independent risk factors
include cigarette smoking, diabetes, high blood pressure,
obesity, and increased total and low-density-lipoprotein
cholesterol [3]. Of emerging importance are certain mater-
nal reproductive factors [4, 5].
The health risks of low-level exposure to ionizing ra-
diation are usually thought to be related primarily to
cancer in the directly-exposed population [6, 7]. Most
cancer types have been associated with radiation exposure,
whether in the Japanese atomic bomb survivors [8, 9] or
in other groups [6]. At high radiation doses (>5 Gy), a
variety of other well established effects are observed; in
particular, damage to the structures of the heart and to
the coronary, carotid, and other large arteries [10]. Several
recent reviews have suggested an excess radiation-induced
risk at occupational and environmental dose levels
(<0.5 Gy 1) [2, 11–15], although the presence and mag-
nitude of low-dose risk is still unclear, with some advo-
cating for the use of a threshold [16, 17]. The results of* Correspondence: mark.little@nih.gov
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plied to various current populations that overall
radiation-related mortality would be about twice that
currently estimated based on estimates for cancer end-
points alone [13].
Here, we briefly summarize the evidence, including
that from several systematic reviews [12-15], for a causal
association between moderate- and low-level radiation
exposure (whether at high or low dose rates) and cardio-
vascular disease because of its potential impact on radi-
ation detriment.Review
Damage to the vasculature can affect the function of
most body organs by restricting blood flow and oxygen
to tissue; however, the heart and brain are of main con-
cern. At high radiation doses (organ doses > 5 Gy), such
as those received by patients treated with radiotherapy, a
variety of adverse effects in the circulatory system have
been reported, among them damage to the structures of
the heart—including marked diffuse fibrotic damage, es-
pecially of the pericardium and myocardium, pericardial
adhesions, microvascular damage, intracardiac conduction
system, and stenosis of the valves—and to the coronary,
carotid, and other large arteries. These effects occur both
in patients receiving radiotherapy and in experimental
animals [10]. There are plausible, if not completelyarticle is distributed under the terms of the Creative Commons Attribution 4.0
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radiation might affect the blood-circulatory system [18].Findings in the Japanese atomic bomb survivors
Excess radiation-associated mortality from heart disease
and stroke has been observed in the Life Span Study
(LSS) cohort (Table 1) [19]. In the latest follow-up of the
Adult Health Study (AHS), a subset of the LSS cohort,
Yamada et al. [20] observed generally non-statistically
significant, radiation-associated excess risks of hypertension
and myocardial infarction (Table 1). Analysis within the
AHS of those exposed in early childhood showed a signifi-
cantly increased incidence of non-fatal stroke or myocardial
infarction, although there was no excess risk among those
exposed in utero for whom the average exposures were
much lower [21] (Table 1). The studies of Yamada et al.
[20] and Tatsukawa et al. [21] were the only epidemiological
reports, apart from those of Ivanov et al. [22] and Azizova
et al. [23, 24], that assessed morbidity rather than mortality.
Some aspects of the Japanese atomic bomb survivor
data imply that risks may not necessarily apply to other
exposed populations. The Japanese atomic bomb survivors,
almost uniquely among the groups considered here, were
exposed at a high dose rate. Survivors suffered from burns,
epilation, and other acute injuries caused by the radiation,
heat, and blast of the bombs, respectively, and these in-
juries, in addition to radiation, may have contributed to
the development of non-cancer diseases in later life. In
addition to the direct effect of the injuries, these and
other trauma might introduce selection bias. Evidence
of such bias has been presented by Stewart and Kneale
[25], who documented the heterogeneity of risk for
various endpoints, in particular cardiovascular disease
mortality, among the various acute-injury groups. How-
ever, Stewart and Kneale [25] did not consider the effects
of dose error. Analysis considering this error provided
much reduced and generally not statistically significant
evidence for a differential effect among those survivors,
especially for cardiovascular disease [26]. Although se-
lection bias cannot be entirely discounted, the general
consistency of risks in the Japanese and other groups
suggests that it does not have a major impact (Table 1).
(For a more formal analysis see reference [13].)Occupationally exposed groups
The International Agency for Research on Cancer 15-
country study of radiation workers found increasing
dose-related trends for mortality from all circulatory
disease, cerebrovascular disease, and other circulatory
diseases and decreasing trends for ischemic heart disease
(IHD), heart failure, deep vein thrombosis, and pulmonary
embolism [27] (Table 1), although none of these trends
was statistically significant (1-sided P ≥ 0.20).Radiation-associated excess IHD and stroke morbidity
were observed in Chernobyl recovery workers, although
morbidity from hypertensive heart disease and other
heart disease was not increased [22] (Table 1).
A highly statistically significant trend with dose was
seen for IHD and cerebrovascular disease in the latest
analysis of circulatory disease morbidity and mortality in
the Mayak workers [23, 24]. The study is unusual in that
doses to certain internal organs, especially the lung and
liver, were dominated by doses from internally deposited
radionuclides; in particular, the α-particle-emitting ra-
dioisotopes of plutonium. Doses in this study are among
the highest considered here and arguably were suffi-
ciently high that this study should be considered outside
the scope of this review: average whole body doses for
external γ rays were 0.5 to 0.6 Gy. However, unlike the
partial-body doses received from radiotherapy, the exter-
nal whole-body doses received by the Mayak workers
generally accumulated over a long time, so it is reason-
able to include this population here.
Nonetheless, interpreting the results of the Mayak cohort
is complicated by the large and highly heterogeneous in-
ternal α-particle dose from plutonium. The dose response
was significant, both in relation to the external γ dose and
the internal (α-particle) dose to the liver [23, 24]. Apart
from these workers, few cohorts with α-particle liver dose
have individual organ dose estimates, or are large enough
to merit analysis of this endpoint. For example, individ-
ual α-particle liver dose was generally not evaluated in
persons exposed to the diagnostic contrast medium
Thorotrast [28].
In the latest analysis of the United Kingdom National
Registry for Radiation Workers [29], circulatory disease
mortality had a borderline significant trend with dose, with
an excess relative risk (ERR) of 0.25 Sv−1 (95 % CI, −0.01 to
0.54). In most other workforces [30–33], there were gener-
ally no statistically significant trends of circulatory disease
with dose (Table 1). Some of these studies overlap and, in
particular, substantial portions of the study populations of
Muirhead et al. [29] are included in the International
Agency for Research on Cancer study [27]. The highly
significant excess risks of circulatory disease in a study
of British Nuclear Fuels plc workers should also be noted
[34]; however, this study is largely subsumed within the
study by Muirhead et al. [29] and has only 4 more years of
follow-up (to December 31, 2005 versus December 31,
2001 for Muirhead et al. [29]).
A study of a cohort of environmentally exposed individ-
uals in the Southern Ural Mountains reported a statistically
significant, or borderline significant, increase (depending
on the latent period used) of both all circulatory disease
mortality, with an ERR of 0.24 Gy−1 (95 % CI, −0.08 to
0.59), and IHD mortality, with an ERR of 0.40 Gy−1
(95 % CI, −0.11 to 0.99) with a 10-year lag [35]. The
Table 1 Estimated excess relative risks of circulatory disease in various studies of moderate- and low-dose radiation exposure. (Ad ed from Little et al. [11, 12]). All data are in
relation to underlying cause of death, unless otherwise indicated




Endpoint (mortality unless otherwi ndicated) Excess relative risk
Sv−1 (95 % CI)
Japanese atomic bomb survivors
Japanese atomic bomb survivors Shimizu et al. [19] 0.1 (0–4)a 86,611 (n.a.) Ischemic heart disease (ICD9 410–4 ) 0.02 (−0.10, 0.15)
Myocardial infarction (ICD9 410) 0.00 (−0.15, 0.18)
Hypertensive heart disease (ICD9 4 404) 0.37 (0.08, 0.72)
Rheumatic heart disease (ICD9 393 8) 0.86 (0.25, 1.72)
Heart failure (ICD9 428) 0.22 (0.07, 0.39)
Other heart disease (ICD9 390–392 5–427, 429) −0.01 (−0.21, 0.24)
Hypertensive disease without hear sease (ICD9 401, 403, 405) 0.07 (−0.22, 0.55)
Heart disease total (ICD9 393–429 luding 401, 403, 405) 0.18 (0.11, 0.25)b
Cerebral infarction (ICD9 433,434) 0.04 (−0.10, 0.20)
Cerebral hemorrhage (ICD9 431) 0.05 (−0.06, 0.17)
Subarachnoid hemorrhage (ICD9 4 0.30 (−0.04, 0.76)
Other or unspecified cerebrovascu disease 0.16 (0.01, 0.34)
Cerebrovascular disease total (ICD9 0–438) 0.12 (0.05, 0.19)b
Circulatory disease apart from hear isease and
stroke (ICD9 390–392, 401, 403, 405 39–459)
0.58 (0.45, 0.72)b
Other circulatory disease (ICD9 399 0, 406–409, 439–459) −0.01 (<−0.01, 0.34)
All circulatory disease (ICD9 390–45 0.15 (0.10, 0.20)b
Japanese atomic bomb survivors Yamada et al. [20] 0.1 (0–4)b 10,339 (n.a.) Hypertension incidence, 1958–1998 D9 401) 0.05 (−0.01, 0.10)c
Hypertensive heart disease inciden 1958–1998 (ICD9 402,
404)
−0.01 (−0.09, 0.09)c
Ischemic heart disease incidence, 1 –1998 (ICD9 410–414) 0.05 (−0.05, 0.16)c
Myocardial infarction incidence, 19 1998 (ICD9 410) 0.12 (−0.16, 0.60)c
Occlusion incidence, 1958–1998 (IC 433, 434) 0.06 (−0.11, 0.30)c
Aortic aneurysm incidence, 1958–1 (ICD9 441, 442) 0.02 (−0.22, 0.41)c
Stroke incidence, 1958–1998 (ICD9 0, 431, 433, 434, 436) 0.07 (−0.08, 0.24)c
Japanese atomic bomb survivors Tatsukawa et al. [21] 0.001 (0–1.79) 506 (9265) Morbidity in utero: hypertension 0.20 (−0.39, 1.38)
Morbidity in utero: nonfatal stroke myocardial infarction −0.91 (−1.00, 79.3)
Japanese atomic bomb survivors Tatsukawa et al. [21] 0.13 (0–3.53) 1053 (20,216) Morbidity: hypertension 0.15 (−0.01, 0.34)


































Table 1 Estimated excess relative risks of circulatory disease in various studies of moderate- and low-dose radiation exposure. (Ada ed from Little et al. [11, 12]). All data are in
relation to underlying cause of death, unless otherwise indicated (Continued)
Occupational studies
Mayak workers Moseeva et al. [24] 0.62 ± 0.80 (males)d 18,856 (356,880) Ischemic heart
disease morbidity
(ICD9 410–414)
0.160 (0.089, 0.230)d, e
Azizova et al. [23] 0.51 ± 0.68 (females)d 22,377 (425,735) Cerebrovascular disease morbidity 9 430–438) 0.49 (0.39, 0.60)d, e
Chernobyl emergency workers Ivanov et al. [22] 0.109 (0 - >0.5) 61,017 (n.a.) Hypertension (ICD10 I10-I15) morbi y 0.26 (−0.04, 0.56)
Essential hypertension (ICD10 I10) m rbidity 0.36 (0.005, 0.71)
Hypertensive heart disease (ICD10 ) morbidity 0.04 (−0.36, 0.44)
Ischemic heart disease (ICD10 I20-I2 morbidity 0.41 (0.05, 0.78)
Acute myocardial infarction (ICD10 ) morbidity 0.19 (−0.99, 1.37)
Other acute ischemic heart disease D10 I24) morbidity 0.82 (−0.62, 2.26)
Angina pectoris (ICD10 I20) morbid 0.26 (−0.19, 0.71)
Chronic ischemic heart disease (ICD I25) morbidity 0.20 (−0.23, 0.63)
Other heart disease (ICD10 I30-I52) rbidity −0.26 (−0.81, 0.28)
Cerebrovascular disease (ICD10 I60- ) morbidity 0.45 (0.11, 0.80)
Morbidity from diseases of arteries, erioles and capillaries
(ICD10 I70-I79)
0.47 (−0.15, 1.09)
Morbidity from diseases of veins, ly hatic vessels
and lymph nodes (ICD10 I80-I89)
−0.26 (−0.70, 0.18)
All circulatory disease (ICD10 I00-I9 orbidity 0.18 (−0.03, 0.39)
German uranium miner study Kreuzer et al. [31] 0.041 (0–0.909)d 58,982 (2,180,639) All circulatory disease (ICD10 I00-I9 −0.13 (−0.38, 0.12)d
Ischemic heart disease (ICD10 I20-I2 −0.03 (−0.38, 0.32)d
Cerebrovascular disease (ICD10 I60- ) 0.44 (−0.16, 1.04)d
Électricité de France workers Laurent et al. [33] 0.0215 (0–0.6) 22,393 (440,984) Ischemic heart disease 4.1 (−2.9, 13.7)f
Cerebrovascular disease 17.4 (0.2, 43.9)f
All circulatory disease 2.7 (−2.3, 9.1)f
Eldorado uranium miners and
processing (male) workers
Lane et al. [32] 0.0522 (<0.0234–
> 0.1215)
16,236 (508,673) Ischemic heart disease 0.15 (−0.14, 0.58)
Stroke −0.29 (<−0.29, 0.27)
All other circulatory disease 0.07 (<−0.33, 0.77)
British Nuclear Fuels plc. workers McGeoghegan et al. [34] 0.0569 (0– > 0.729) 38,779 (1,081,570) Ischemic heart disease (ICD9 410–4 ) 0.70 (0.37, 1.07)b, f






























Table 1 Estimated excess relative risks of circulatory disease in various studies of moderate- and low-dose radiation exposure. (Adapted from Little et al. [11, 12]). All data are in
relation to underlying cause of death, unless otherwise indicated (Continued)
Other circulatory diseases (ICD9 390–398, 415–429, 440–459) 0.83 (−0.10, 1.12)f
Circulatory diseases apart from cerebrovascular (ICD9
390–429, 439–459)
0.72 (0.39, 1.10)f
All circulatory disease (ICD9 390–459) 0.54 (0.30, 0.82)b, f
3rd Analysis of UK National Registry
for Radiation Workers
Muirhead et al. [29] 0.0249 (<0.01– > 0.4) 174,541 (3.9 × 106) All circulatory disease (ICD9 390–459) 0.251 (−0.01, 0.54)
Circulatory disease not strongly related to smoking (ICD9
390–409, 415–440, 442–459)
0.280 (−0.19, 0.85)
Aortic aneurysm (ICD9 441) −0.132 (−1.29, 1.92)
Ischemic heart disease (ICD9 410–414) 0.259 (−0.05, 0.61)
Cerebrovascular disease (ICD9 430–438) 0.161 (−0.42, 0.91)
US Oak Ridge workers Richardson and Wing [63] n.a. (0– > 0.1) 14,095 (425,486) Ischemic heart disease (ICD8 410–414) −2.86 (−6.90, 1.18)
International Agency for Research
on Cancer15-country nuclear
worker study
Vrijheid et al. [27] 0.0207 (0.0– > 0.5) 275,312 (4,067,861) Circulatory disease (ICD10 I00-I99, J60-J69, O88.2, R00-R02,
R57)
0.09 (−0.43, 0.70)
Ischemic heart disease (ICD10 I20-I25) −0.01 (−0.59, 0.69)
Heart failure (ICD10 I50) −0.03 (<0, 4.91)
Deep vein thrombosis and pulmonary embolism (ICD10 I26,
I80, I82, O88.2)
−0.95 (−1.00, 9.09)g
Cerebrovascular disease (ICD10 I60-I69) 0.88 (−0.67, 3.16)
All other circulatory disease (ICD10 R00-R02, R57, I00-I99
excluding I20-26, I50, I60-69, I80, I82)
0.29 (<0, 2.40)
Environmental studies
Three Mile Island study Talbott et al. [64] 0.0001 (0– > 0.00016) 32,135 (561,063) Heart disease (white males) −274 (−874, 438)
Heart disease (white females) −951 (−1433, −390)
Techa River study Krestinina et al. [35] 0.035 (0–0.51)h 29,735 (901,563) All circulatory disease mortality (ICD9 390–459) (10 year lag) 0.24 (−0.08, 0.59)
All circulatory disease mortality (ICD9 390–459) (15 year lag) 0.36 (0.02, 0.75)
Ischemic heart disease mortality (ICD9 410–414) (10 year lag) 0.40 (−0.11, 0.99)
Ischemic heart disease mortality (ICD9 410–414) (15 year lag) 0.56 (0.01, 1.19)
Semipalatinsk nuclear test study Grosche et al. [36] 0.09 (0–0.63)d 19,545 (582,656) Heart disease (ICD9 410–429): all settlements 3.22 (2.33, 4.10)d
Heart disease (ICD9 410–429): exposed settlements 0.06 (−0.39, 0.52)d











Table 1 Estimated excess relative risks of circulatory disease in various studies of moderate- and low-dose radiation exposure. (Adapted from Little et al. [11, 12]). All data are in
relation to underlying cause of death, unless otherwise indicated (Continued)
Stroke (ICD9 430–438): exposed settlements −0.06 (−0.65, 0.54)d
Cardiovascular disease (ICD9 390–459): all settlements 3.15 (2.48, 3.81)d
Cardiovascular disease (ICD9 390–459): exposed settlements 0.02 (−0.32, 0.37)d
CI Confidence Interval, ICD International Classification of Diseases
aAnalysis based on colon dose
bAnalysis using underlying or contributing cause of death
c Analysis based on stomach dose, derived from Table 4 of Yamada et al. [20] with smoking and drinking in the stratification
dRisk estimates in relation to cumulative whole body external gamma dose; doses given here are from Moseeva et al. [24]
eAssuming a lag period of 10 years
f90 % CI
gEstimate derived from log-linear model, evaluated at 1 Sv
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of 15 to 20 years, but not significant (P > 0.1) with lags
of 0 to 10 years [35].
Grosche et al. [36] studied circulatory disease mortality
in a Kazakhstan group exposed to fallout from nuclear
weapons tests at the Semipalatinsk site. No excess circu-
latory disease risk was reported in the group of exposed
settlements, with an ERR of 0.02 Gy−1 (95 % CI, −0.32 to
0.37) for cardiovascular disease, an ERR of 0.06 Gy−1
(95 % CI, −0.39 to 0.52) for heart disease, and an ERR
of −0.06 Gy−1 (95 % CI, −0.65 to 0.54) for stroke. On
the other hand, if exposed and unexposed settlements
were analyzed together, the excess risks were highly sta-
tistically significant and implausibly large, an ERR of
3.15 Gy−1 (95 % CI, 2.48 to 3.81) for circulatory disease,
an ERR of 3.22 Gy−1 (95 % CI, 2.33 to 4.10) for heart
disease, and an ERR of 2.96 Gy−1 (95 % CI, 1.77 to
4.14) for stroke. The dosimetry in this cohort is prob-
lematic because it is based on assessments of residence,
estimates of time spent outdoors, and diet, all of which
were collected by interviews more than 30 years after
the bomb tests. As such, the results of this study are
largely uninformative.
Radiation-associated excess relative risk for circulatory
disease does not substantially vary by sex, time since ex-
posure, or age at exposure in Japanese atomic bomb sur-
vivors [37, 38], although there are borderline significant
decreasing trends with attained age [13, 19]. Increasing
time trends have been observed in other groups [27].
Discussion
Most of the studies considered here involved low to mod-
erate average cumulative radiation doses (0.2 Gy or less),
with participants in the occupational studies exposed at
near-background dose rates. Nevertheless, the small num-
bers of participants exposed at high cumulative doses
(0.5 Gy or above) drive the observed trends in most co-
horts with these higher dose groups (see Table 1).
A particular limitation of many studies considered
here is the absence of information on lifestyle, medical
and other covariates linked with risk of circulatory disease.
Of the studies considered only those of the Japanese
atomic bomb survivors [19] and Mayak workers [23, 24]
had information on lifestyle factors, in particular cigarette
smoking, alcohol consumption, obesity and (in the LSS) a
few other variables associated with circulatory disease
(diabetes mellitus, education, household occupation). The
substantial heterogeneity that was observed for cerebro-
vascular disease and circulatory disease apart from heart
disease and cerebrovascular disease in the previous meta-
analysis [13] may not be surprising given the variation in
the distributions of different risk factors across popula-
tions, but it limits interpretation of the observed associ-
ations for these endpoints. However, in most radiation-exposed groups there is little or no evidence that life-
style factors, when available, interact with radiation-
associated circulatory disease risk [19, 23, 24, 39].
There have been a number of recent reviews of candidate
biological mechanisms [2, 11, 18]. At high radio-therapeutic
doses (>5 Gy), the cell-killing effect on capillaries and
endothelial cells plausibly explains effects on the circu-
latory system [18]. At lower doses (0.5–5 Gy), in humans
and in experimental studies, many inflammatory markers
are up-regulated long after exposure to radiation. How-
ever, for exposures less than about 0.5 Gy, the balance
shifts toward anti-inflammatory effects [11, 40]. Inter-
estingly, there is evidence of a steeper dose–response
slope for various types of circulatory disease under
0.5 Gy in the US radiologic technologists [41], as also
in two groups given highly fractionated fluoroscopic X-ray
exposures [42, 43].
The generally uniform whole-body, low linear energy
transfer radiation in the cohorts we assessed is unin-
formative as to specific target tissues. What the target
tissues are for circulatory system effects at moderate and
low doses (<0.5 Gy) remains uncertain. Dose-related var-
iations in T-cell and B-cell populations in Japanese atomic
bomb survivors suggest that the immune system may be
adversely affected [44]. There is at best conflicting evi-
dence for involvement of the immune system in cardio-
vascular disease [45–49]; to the extent that it might be,
whole-body or bone-marrow dose could be the most
relevant to radiation effects. A mechanism based on
monocyte cell killing in the arterial intima suggests that
the target for atherosclerosis is the arterial intima [50];
however, this mechanism remains speculative. There is
nevertheless suggestive evidence for radiation-induced
endothelial cell senescence and associated monocyte ad-
hesion [51]. There is support for the kidney being the tar-
get tissue in relation to hypertension in the LSS cohort
[52] and in experimental animal data [53].
Diabetes and obesity are major risk factors for circula-
tory disease [3], the former suggesting that the pancreas
may be an etiologically relevant target tissue. Many of the
metabolic derangements known to occur in diabetes,
including hyperglycemia, excess free fatty acid liberation,
and insulin resistance, mediate abnormalities in endothe-
lial cell function [54]. Endothelial cells, because of their
strategic anatomic position between the circulating blood
and the vessel wall, regulate vascular function and struc-
ture; dysfunctions in endothelial cells are thought to be a
critical initiating stage in many types of circulatory disease
[54]. It has generally been assumed that the heart is the
most etiologically relevant target tissue for IHD, and the
dose to the heart is often used in analysis of radiation-
induced IHD [39, 55]. The critical role of vascular endo-
thelial cells in circulatory disease discussed above suggests
that the large arteries (e.g., aorta, carotid), may also be an
Little and Lipshultz Cardio-Oncology  (2015) 1:4 Page 8 of 10etiologically relevant target. In the peptic ulcer disease co-
hort there is a highly significant excess risk of IHD, and a
borderline significant excess of cerebrovascular disease
[56]. Little et al. [56] considered risk of these endpoints in
relation to doses to a number of candidate tissues, includ-
ing the heart, kidney, thyroid (a surrogate for the carotid
artery), pancreas (a surrogate for liver, important also for
diabetes) and brain; in relation at least to IHD, the kidney
appeared to be etiologically plausible, given the similarity
of risk estimates based on kidney-dose with those derived
from uniform whole body irradiation in other cohorts, in
particular the LSS and various other uniform-whole-body
exposed datasets [13]. There is other evidence suggesting
a role for radiation therapy, and specifically dose to the
pancreas, in causing diabetes, both in the peptic ulcer dis-
ease cohort [57] and elsewhere [58, 59]; however, the role
of ionizing radiation in inducing diabetes at the lower
doses that are the focus of this review remains uncertain,
since, based on an early report, no increase has been ob-
served in the AHS [60]. Parathyroid hormone increases
with dose in the Japanese atomic bomb survivors, suggest-
ing that there may be radiation-associated hyperparathyr-
oidism [61]. Parathyroid hormone (PTH) has a central
role in well-regulated calcium homeostasis and its release
is triggered by a decrease in serum calcium levels. Primary
hyperparathyroidism results in overproduction of PTH,
mobilizing excess calcium to the bloodstream [62]. This
elevation results in hypertension (via disturbances in
the renin-angiotensin-aldosterone system), cardiac
hypertrophy, and myocardial dysfunction [62]. PTH re-
ceptors are present in the myocardium and exert hyper-
trophic effects on cardiomyocytes [62]. These associations
suggest plausible mechanisms whereby the elevated PTH
concentrations that result from hyperparathyroidism may
be involved in various pathological processes that lead to
circulatory disease.Conclusions
The evidence in this review provides suggestive evidence
in support of a causal association between moderate- and
low-level radiation exposure and circulatory disease. How-
ever, the substantial heterogeneity for certain endpoints
limits interpretation of the epidemiological associations.Endnotes
1The equivalent dose, in sievert (Sv), with different
types of radiation absorbed dose weighted by their bio-
logical effectiveness at inducing stochastic effects, is nu-
merically very close to the (unweighted) absorbed dose,
in gray (Gy), for all studies considered here.
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